Correction: miR-9-5p, miR-124-3p, and miR-132-3p regulate BCL2L11 in tuberous sclerosis complex angiomyolipoma

Correction to: Laboratory Investigation 98, 856–870 (2018); https://doi.org/10.1038/s41374-018-0051-6; published online 14 March 2018

Following the publication of this article, the authors noticed an error in Fig. 5c. In the miR-132-3p mimics. This does not affect the results and conclusions of the article. The correct version of Fig. 5 can be found below.

Fig. 5

The role of miR-9-5p, miR-124-3p, and miR-132-3p in the regulation of proliferation and apoptosis in Tsc2^−/− cells. a CCK-8 assays were performed 24, 48, 72, and 96 h after the transfection of Tsc2^−/− cells with miR-9-5p, miR-124-3p, or miR-132-3p mimics or the scrambled control. b CCK-8 assays were performed 24, 48, 72, and 96 h after the transfection of Tsc2^−/− cells with miR-9-5p, miR-124-3p, or miR-132-3p inhibitors or the negative control. c, d Tsc2^−/− cells were transfected with equal doses of miR-9-5p, miR-124-3p, or miR-132-3p mimics or the scrambled control. The cell apoptosis profiles were analyzed by flow cytometry. The bi-parametric histogram shows cells in early (bottom right quadrant) and late (top right quadrant) apoptotic states. Viable cells are double negative (bottom left quadrant). c Representative image. d Quantitative analysis. e, f Tsc2^−/− cells were transfected with equal doses of miR-9-5p, miR-124-3p, or miR-132-3p inhibitors or the negative control. The cell apoptosis profiles were analyzed by flow cytometry. The bi-parametric histogram shows cells in early (bottom right quadrant) and late (top right quadrant) apoptotic states. Viable cells are double negative (bottom left quadrant). e Representative image. f Quantitative analysis